Abstract
The purpose of this study is to determine whether Heat Shock Protein Peptide Complex-96
(HSPPC-96) Vaccine is an feasible and safe treatment for pediatric patients with
newly-diagnosed High-Grade Gliomas or recurrent, resectable High-Grade Gliomas and
Ependymomas.

